ArticleThrombosis journal2022

The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China.

Jiawen Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.